International Cardiac Amyloidosis Registry

计划入组 300 人 · 首次发布于 2025 年 3 月 25 日

Cardiac Amyloidosis Discovery Trial

计划入组 50 人 · 首次发布于 2024 年 6 月 21 日

Cardiac Amyloidosis Registry Study

计划入组 5,000 人 · 首次发布于 2021 年 12 月 30 日

amyloidosis therapy, orphanbiotec

cardiac selective mineralocorticoid receptor inhibitors (oral, cardiac failure/cardiac fibrosis)

Cardiac Fibrosis(Hepion)

Cardiac Implants LLC

United States

CARDIAC DIMENSIONS PTY. LTD.

Australia

TEXAS CARDIAC ARRHYTHMIA RESEARCH FOUNDATION

United States

FDA Clears AI-Powered Ultrasound Software EchoGo® Amyloidosis for Enhanced Cardiac Amyloidosis Detection

Ultromics' AI Software for Cardiac Amyloidosis Receives FDA Approval

Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection